CO2019006311A2 - N-acetilcisteína para su uso como agente antibacteriano - Google Patents
N-acetilcisteína para su uso como agente antibacterianoInfo
- Publication number
- CO2019006311A2 CO2019006311A2 CONC2019/0006311A CO2019006311A CO2019006311A2 CO 2019006311 A2 CO2019006311 A2 CO 2019006311A2 CO 2019006311 A CO2019006311 A CO 2019006311A CO 2019006311 A2 CO2019006311 A2 CO 2019006311A2
- Authority
- CO
- Colombia
- Prior art keywords
- acetylcysteine
- antibacterial agent
- maltophilia
- burkholdeira
- acetycysteine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Abstract
RESÚMEN La presente invención se refiere a la N-acetlicisteína para su uso en el tratamiento de infecciones bacterianas causadas por un patógeno seleccionado de las cepas del Complejo de Burkholdeira cepacia (BBC) y Stenotrophomas maltophilia (S.maltophilia).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16204412 | 2016-12-15 | ||
PCT/EP2017/082512 WO2018108960A1 (en) | 2016-12-15 | 2017-12-13 | N-acetylcysteine for use as antibacterial agent |
Publications (1)
Publication Number | Publication Date |
---|---|
CO2019006311A2 true CO2019006311A2 (es) | 2020-01-17 |
Family
ID=57614136
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CONC2019/0006311A CO2019006311A2 (es) | 2016-12-15 | 2019-06-17 | N-acetilcisteína para su uso como agente antibacteriano |
Country Status (20)
Country | Link |
---|---|
US (2) | US20200093774A1 (es) |
EP (2) | EP3861994A1 (es) |
JP (1) | JP2020502096A (es) |
CN (1) | CN110049761A (es) |
AU (1) | AU2017376391B2 (es) |
BR (1) | BR112019011708A2 (es) |
CA (1) | CA3045730A1 (es) |
CO (1) | CO2019006311A2 (es) |
DK (1) | DK3554491T3 (es) |
EA (1) | EA201991331A1 (es) |
ES (1) | ES2942764T3 (es) |
FI (1) | FI3554491T3 (es) |
HR (1) | HRP20230369T1 (es) |
HU (1) | HUE061995T2 (es) |
LT (1) | LT3554491T (es) |
PL (1) | PL3554491T3 (es) |
PT (1) | PT3554491T (es) |
RS (1) | RS64201B1 (es) |
SI (1) | SI3554491T1 (es) |
WO (1) | WO2018108960A1 (es) |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1231012B (it) * | 1989-07-27 | 1991-11-08 | Zambon Spa | Composizione farmaceutica per uso orale contenente nac. |
US6475434B1 (en) * | 1998-12-07 | 2002-11-05 | Baylor College Of Medicine | Composition and methods for preventing and removing biofilm embedded microorganisms from the surface of medical devices |
US7214364B2 (en) * | 2000-12-27 | 2007-05-08 | Corus Pharma, Inc. | Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections |
US6566401B2 (en) | 2001-03-30 | 2003-05-20 | The Board Of Trustees Of The Leland Stanford Junior University | N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity |
ITMI20021405A1 (it) * | 2002-06-25 | 2003-12-29 | Zambon Spa | Composizioni farmaceutiche per il trattamento di infezioni da patogeni dell'apparato respiratorio |
US8148356B2 (en) * | 2005-08-24 | 2012-04-03 | Cumberland Pharmaceuticals, Inc. | Acetylcysteine composition and uses therefor |
CA2662636C (en) | 2008-04-15 | 2017-01-24 | The Board Of Trustees Of The Leland Stanford Junior University | N-acetylcysteine compositions and methods for treating acute exacerbations of inflammatory lung disease |
GB0905451D0 (en) * | 2009-03-31 | 2009-05-13 | Novabiotics Ltd | Biofilms |
IT1399492B1 (it) | 2010-04-13 | 2013-04-19 | Alpex Pharma Sa | Composizioni farmaceutiche effervescenti contenenti n-acetilcisteina. |
GB201021186D0 (en) * | 2010-12-14 | 2011-01-26 | Novabiotics Ltd | Composition |
ITMI20130874A1 (it) * | 2013-05-29 | 2014-11-30 | Zambon Spa | Compresse deglutibili di n-acetilcisteina |
SG11201601291QA (en) * | 2013-08-23 | 2016-03-30 | Parion Sciences Inc | Dithiol mucolytic agents |
WO2016120787A1 (en) | 2015-01-26 | 2016-08-04 | Novartis Consumer Health S.A. | Oral n-acetylcysteine in the treatment of upper respiratory tract infections and symptoms |
-
2017
- 2017-12-13 LT LTEPPCT/EP2017/082512T patent/LT3554491T/lt unknown
- 2017-12-13 DK DK17825431.4T patent/DK3554491T3/da active
- 2017-12-13 PT PT178254314T patent/PT3554491T/pt unknown
- 2017-12-13 CA CA3045730A patent/CA3045730A1/en active Pending
- 2017-12-13 SI SI201731343T patent/SI3554491T1/sl unknown
- 2017-12-13 FI FIEP17825431.4T patent/FI3554491T3/fi active
- 2017-12-13 PL PL17825431.4T patent/PL3554491T3/pl unknown
- 2017-12-13 RS RS20230305A patent/RS64201B1/sr unknown
- 2017-12-13 EP EP21163647.7A patent/EP3861994A1/en active Pending
- 2017-12-13 HU HUE17825431A patent/HUE061995T2/hu unknown
- 2017-12-13 EA EA201991331A patent/EA201991331A1/ru unknown
- 2017-12-13 EP EP17825431.4A patent/EP3554491B1/en active Active
- 2017-12-13 BR BR112019011708A patent/BR112019011708A2/pt active Search and Examination
- 2017-12-13 CN CN201780076376.2A patent/CN110049761A/zh active Pending
- 2017-12-13 AU AU2017376391A patent/AU2017376391B2/en active Active
- 2017-12-13 HR HRP20230369TT patent/HRP20230369T1/hr unknown
- 2017-12-13 ES ES17825431T patent/ES2942764T3/es active Active
- 2017-12-13 WO PCT/EP2017/082512 patent/WO2018108960A1/en unknown
- 2017-12-13 JP JP2019531147A patent/JP2020502096A/ja active Pending
- 2017-12-13 US US16/468,716 patent/US20200093774A1/en not_active Abandoned
-
2019
- 2019-06-17 CO CONC2019/0006311A patent/CO2019006311A2/es unknown
-
2020
- 2020-12-28 US US17/134,719 patent/US11918552B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
FI3554491T3 (fi) | 2023-04-26 |
PT3554491T (pt) | 2023-05-04 |
PL3554491T3 (pl) | 2023-07-17 |
ES2942764T3 (es) | 2023-06-06 |
RS64201B1 (sr) | 2023-06-30 |
US20200093774A1 (en) | 2020-03-26 |
EP3554491A1 (en) | 2019-10-23 |
LT3554491T (lt) | 2023-05-25 |
DK3554491T3 (en) | 2023-05-15 |
CN110049761A (zh) | 2019-07-23 |
CA3045730A1 (en) | 2018-06-21 |
AU2017376391A1 (en) | 2019-06-20 |
EP3554491B1 (en) | 2023-02-15 |
EA201991331A1 (ru) | 2019-11-29 |
WO2018108960A1 (en) | 2018-06-21 |
HUE061995T2 (hu) | 2023-09-28 |
BR112019011708A2 (pt) | 2019-10-15 |
EP3861994A1 (en) | 2021-08-11 |
US20210113508A1 (en) | 2021-04-22 |
JP2020502096A (ja) | 2020-01-23 |
US11918552B2 (en) | 2024-03-05 |
HRP20230369T1 (hr) | 2023-06-23 |
SI3554491T1 (sl) | 2023-06-30 |
AU2017376391B2 (en) | 2023-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2017013443A2 (es) | Composiciones que comprenden cepas bacterianas del género blautia | |
CY1124663T1 (el) | Αντιιικα παραγωγα ν4-υδροξυκυτιδινης | |
MX2023003461A (es) | Tratamiento de infeccion por clostridium difficile. | |
GT201600183A (es) | Compuestos orgánicos de monobactam para el tratamiento de infecciones bacterianas | |
CL2018003425A1 (es) | Composiciones de cannabidiol y usos de las mismas. | |
PH12016501512A1 (en) | Treatment for resistant acne | |
PH12015502261A1 (en) | Macrocyclic deaza-purinones for the treatment of viral infections | |
CL2016002027A1 (es) | Ciclopropilamina como inhibidor de la lsd1 | |
PH12015501648A1 (en) | 2-aminopyrimidine derivatives for the treatment of viral infections | |
CL2016002971A1 (es) | Combinación. | |
MX2018001075A (es) | Agentes terapeuticos y profilacticos antibacterianos. | |
CL2017002176A1 (es) | Identificación bacteriana y prueba de susceptibilidad antimicrobiana. | |
UY34201A (es) | Compuestos de azaindol y métodos para el tratamiento de vih. | |
BR112018074454A2 (pt) | composições e métodos de uso de nintedanib para tratar doenças oculares com neovascularização anormal | |
CL2015003019A1 (es) | Derivados biaromáticos antibacterianos | |
BR112016024096A2 (pt) | novo bacteriófago e composição compreendendo o mesmo | |
BR112017005272A2 (pt) | uso de cisteamina no tratamento de infecções causadas por leveduras/bolores | |
CL2016002879A1 (es) | Composiciones farmacéuticas para tratar enfermedades infecciosas | |
PH12017500602A1 (en) | Methods for treating ocular conditions | |
MX363631B (es) | Composiciones y metodos para tratar infecciones bacterianas. | |
PH12016501434A1 (en) | Compositions for use in the treatment of allergic conditions | |
CL2016001977A1 (es) | Composición que comprende igm derivada de plasma y su uso para el tratamiento o prevención de afecciones inmunitarias. | |
DOP2017000115A (es) | Composiciones farmacéuticas de acción prolongada para la hepatitis c | |
MX2018000384A (es) | Composiciones para el tratamiento contra infecciones. | |
IL256162A (en) | An amino thiol for use in the treatment of an infection caused by the bacterium mycobacterium spp. |